NervGen Pharma Corp
XTSX:NGEN

Watchlist Manager
NervGen Pharma Corp Logo
NervGen Pharma Corp
XTSX:NGEN
Watchlist
Price: 7.68 CAD 11.14% Market Closed
Market Cap: 564.9m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of NGEN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NGEN Intrinsic Value
Not Available
Base Case Scenario
Compare NGEN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NGEN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
NervGen Pharma Corp

Current Assets 12.7m
Cash & Short-Term Investments 11.4m
Receivables 377.4k
Other Current Assets 912.8k
Non-Current Assets 423.2k
Intangibles 423.1k
Other Non-Current Assets 100
Current Liabilities 16m
Accounts Payable 4.4m
Accrued Liabilities 1m
Other Current Liabilities 10.6m
Efficiency

Free Cash Flow Analysis
NervGen Pharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
NervGen Pharma Corp

Revenue
0 CAD
Operating Expenses
-25.5m CAD
Operating Income
-25.5m CAD
Other Expenses
-336.5k CAD
Net Income
-25.8m CAD
Fundamental Scores

NGEN Profitability Score
Profitability Due Diligence

NervGen Pharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

NervGen Pharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NGEN Solvency Score
Solvency Due Diligence

NervGen Pharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

NervGen Pharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NGEN Price Targets Summary
NervGen Pharma Corp

Wall Street analysts forecast NGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NGEN is 7.75 CAD with a low forecast of 5.05 CAD and a high forecast of 10.19 CAD.

Lowest
Price Target
5.05 CAD
34% Downside
Average
Price Target
7.75 CAD
1% Upside
Highest
Price Target
10.19 CAD
33% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

NervGen Pharma Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for NGEN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y